About Amgen. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies and has reached millions of patients globally.
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
At Janssen Oncology, our purpose is to make cancer a manageable and, ultimately, curable condition. We understand that the power to change the lives of those living with cancer begins with a very considered step forwards. Whether it’s from finding novel solutions, a new indication approval, or even just reaching one more patient. That’s The Power of Purpose™.
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
As a leading global medicines company, we use innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development.
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.
For more than 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer.
Mirati Therapeutics, Inc.
Mirati Therapeutics, is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet need and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer.
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Tumor Treating Fields are electric fields that disrupt cancer cell division. Novocure’s commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma.
Sanofi Genzyme and Regeneron
Sanofi Genzyme is advancing transformative therapies with innovative platforms to help improve the lives of people with cancer. Since 2007, Regeneron and Sanofi have collaborated to help people with debilitating and complex conditions that are often difficult to diagnose and treat, using fully-human monoclonal antibodies.
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere.
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. We are enabling precision oncology with easily implementable next-generation sequencing (NGS) Oncomine solutions. Our latest development, the Genexus system, provides a highly automated end-to-end workflow allowing laboratories to deliver NGS results in as little as one day, at the same time as single-gene methods.
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide.
We are passionate about our people, science, and creating a lasting impact. We strive to build a global organization recognized for its impact in cancer research and drug development.
The European School of Oncology (ESO) is an independently funded non-profit organisation dedicated to quality education and training, because we believe all patients deserve equal access to competent cancer care. Our Vision: “To ensure that all cancer patients have access to unbiased and evidence-based competent care from adequately trained health professionals”.